Literature DB >> 30109012

Synthesis and antiplasmodial activity of purine-based C-nucleoside analogues.

Kartikey Singh1, Prince Joshi2, Rohit Mahar3, Pragati Baranwal1, Sanjeev K Shukla3, Renu Tripathi2, Rama Pati Tripathi1.   

Abstract

A series of homologous C-nucleoside mimics have been synthesized via an efficient and facile synthetic protocol involving the conjugate addition of purine to sugar derived olefinic ester in good yields. The synthesized compounds were evaluated for their antiplasmodial activity in vitro against both the CQ-sensitive and resistant strains of P. falciparum. Interestingly, all the synthesized nucleoside analogs exhibited an IC50 of <5 μM, while compounds 22a, 23a, and 23b showed promising antiplasmodial activity with an IC50 of 1.61, 0.88, and 1.01 μM against the CQ-sensitive Pf3D7 strain and 1.14, 1.01, and 2.57 μM against the CQ-resistant PfK1 strain, respectively.

Entities:  

Year:  2018        PMID: 30109012      PMCID: PMC6071838          DOI: 10.1039/c8md00098k

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  24 in total

1.  Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum.

Authors:  L Harmse; R van Zyl; N Gray; P Schultz; S Leclerc; L Meijer; C Doerig; I Havlik
Journal:  Biochem Pharmacol       Date:  2001-08-01       Impact factor: 5.858

2.  Irreversible inhibition of S-adenosylmethionine decarboxylase in Plasmodium falciparum-infected erythrocytes: growth inhibition in vitro.

Authors:  P S Wright; T L Byers; D E Cross-Doersen; P P McCann; A J Bitonti
Journal:  Biochem Pharmacol       Date:  1991-06-01       Impact factor: 5.858

3.  Solid phase synthesis and antiprotozoal evaluation of di- and trisubstituted 5'-carboxamidoadenosine analogues.

Authors:  Boris Rodenko; Remko J Detz; Victorine A Pinas; Catia Lambertucci; Reto Brun; Martin J Wanner; Gerrit-Jan Koomen
Journal:  Bioorg Med Chem       Date:  2005-10-24       Impact factor: 3.641

Review 4.  Drug-resistant malaria: molecular mechanisms and implications for public health.

Authors:  Ines Petersen; Richard Eastman; Michael Lanzer
Journal:  FEBS Lett       Date:  2011-04-23       Impact factor: 4.124

Review 5.  Purine and pyrimidine pathways as targets in Plasmodium falciparum.

Authors:  María Belén Cassera; Yong Zhang; Keith Z Hazleton; Vern L Schramm
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 6.  Recent advances in antimalarial drug development.

Authors:  Suryanaryana Vangapandu; Meenakshi Jain; Kirandeep Kaur; Premanand Patil; Sanjay R Patel; Rahul Jain
Journal:  Med Res Rev       Date:  2007-01       Impact factor: 12.944

7.  Well-defined DNA-mimic brush polymers bearing adenine moieties: synthesis, layer-by-layer self-assembly, and biocompatibility.

Authors:  Jin Chul Kim; Jungwoon Jung; Yecheol Rho; Mihee Kim; Wonsang Kwon; Heesoo Kim; Ik Jung Kim; Jung Ran Kim; Moonhor Ree
Journal:  Biomacromolecules       Date:  2011-05-27       Impact factor: 6.988

Review 8.  New antimalarials. A risk-benefit analysis.

Authors:  F Nosten; R N Price
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

9.  Direct N9-arylation of purines with aryl halides.

Authors:  Anders Foller Larsen; Trond Ulven
Journal:  Chem Commun (Camb)       Date:  2014-05-21       Impact factor: 6.222

10.  Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase.

Authors:  Gary B Evans; Richard H Furneaux; Andrzej Lewandowicz; Vern L Schramm; Peter C Tyler
Journal:  J Med Chem       Date:  2003-07-17       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.